casgevy
-
Americas FDA Approves Groundbreaking CRISPR-Based Treatment, Offering Hope to Sickle Cell Patients
Image Credit: NHLBI In a historic move, the Food and Drug Administration (FDA) has granted approval for Casgevy, a powerful treatment for sickle cell disease, affecting over 100,000 Americans, primarily from the Black community. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, this...- Nigeria News
- Article
- 2 min read
- casgevy crispr therapeutic fda sickle cell cure sickle cell disease vertex pharmaceuticals
- Category: Metro
About Nigerian Bulletin
Nigerian Bulletin is your gateway to top news, specialized lifestyle topics, and a unique, curated marketplace. It connects Nigerians worldwide with crucial updates and opportunities and is ideal for engaging press releases, effective sponsored posts, banner ads, and product showcases.